ArticleCureus2026
Triple Vector-Borne Co-infection During Pregnancy in the United Arab Emirates: A Case Report at 21 Weeks' Gestation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnancy is a unique physiological state characterised by altered immune responses that may predispose women to severe manifestations of infection. Vector-borne diseases such as malaria and dengue pose significant risks to pregnant women and their foetuses, including miscarriage, preterm labour, placental abruption, and intrauterine growth restriction (IUGR). Co-infection with multiple vector-borne pathogens is extremely rare but can exacerbate maternal morbidity and complicate foetal outcomes. This case report aims to describe the clinical presentation, diagnosis, management, and maternal and foetal outcomes of a rare triple vector-borne co-infection during pregnancy. A 32-year-old pregnant woman at 21 weeks of gestation presented with a triple vector-borne infection involving
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.